CDH1 and neoplasm: In contrast, there were no significant associations between survival and age, tumor location, tumor size, extent of resection, β-catenin immunostaining, molecular cytogenetic abnormalities, or proliferative indices, nor between E-cadherin immunostaining and any of those parameters in this patient population (p>0.05).